secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001104659-25-124189
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio terminates CD20 CAR-T license with Fred Hutch, pays $730K to settle $1.4M in payables
--------------------------------------------------------------------------------

- Terminated CD20 CAR-T license with Fred Hutch; agreed to pay $730,000 to settle ~$1.4M in outstanding payables.
- Fred Hutch to pay Mustang at least 10% of consideration from any third-party CD20 licensing within three years.
- All four proposals passed at Dec 22 annual meeting: directors elected, KPMG ratified, ESPP shares raised to 259,333, EIP to 2,514,666.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925124189/0001104659-25-124189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925124189/tmb-20251217x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-124189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer